Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coombs--negative immune hemolytic anemia.

B C Gilliland

    Seminars in Hematology
    |October 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    A rare form of immune hemolytic anemia can occur even when antibody levels on red blood cells are undetectable by standard tests. These patients often respond well to treatments like steroids and splenectomy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rheumatoid arthritis: a model of chronic inflammation.

    Arzneimittel-Forschung·1989
    Same author

    The limited spectrum of antinuclear antibodies in leprosy.

    The Journal of rheumatology·1987
    Same author

    Management of rheumatoid arthritis.

    Disease-a-month : DM·1986
    Same author

    Serum sickness and immune complexes.

    The New England journal of medicine·1984
    Same author

    Detection of intermediate complexes by evaluation of the difference between gamma-globulin and IgG concentrations.

    Arthritis and rheumatism·1979
    Same author

    Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis.

    Infection and immunity·1978
    Same journal

    Pain in SCD-Many mechanisms and mysteries.

    Seminars in hematology·2026
    Same journal

    The many facets of cardiopulmonary complications in sickle cell disease.

    Seminars in hematology·2026
    Same journal

    Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

    Seminars in hematology·2026
    Same journal

    Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

    Seminars in hematology·2026
    Same journal

    Telomeres biology disorders: the past, the present and the future.

    Seminars in hematology·2026
    Same journal

    Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

    Seminars in hematology·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Internal Medicine

    Background:

    • Immune hemolytic anemia (IHA) is typically diagnosed using the antiglobulin test (Coombs test).
    • Some patients present with clinical signs of IHA despite undetectable antibody levels on red blood cells via standard antiglobulin testing.
    • This subgroup represents a diagnostic challenge within hemolytic anemias.

    Purpose of the Study:

    • To describe the clinical characteristics and management of patients with immune hemolytic anemia and low, undetectable levels of red blood cell-bound antibody.
    • To explore the potential mechanisms underlying hemolytic anemia in the presence of minimal antibody coating.
    • To evaluate the therapeutic response in this specific patient population.

    Main Methods:

    • Clinical case review and analysis.

    Related Experiment Videos

  • Immunological assessment of red blood cell-bound antibodies.
  • Evaluation of treatment outcomes (steroid therapy, splenectomy).

    • Main Results:

    • Patients exhibit clinical features similar to Coombs-positive warm autoimmune hemolytic anemia.
    • The concentration of antibody on red blood cells is below the detection threshold of standard antiglobulin tests.
    • The course of the hemolytic disease is variable, influenced by antibody properties and reticuloendothelial system sensitivity.

    Conclusions:

    • Hemolytic anemia can occur with very low concentrations of red blood cell-bound antibody, below standard detection limits.
    • Antibody characteristics and reticuloendothelial system function are key factors in the pathogenesis.
    • Steroid therapy and splenectomy are generally effective treatments when indicated for these patients.